Skip to main content
Premium Trial:

Request an Annual Quote

Cue Health Files for Full FDA Clearance of COVID-19 Molecular Test

The story has been corrected to state that two COVID-19 tests have so far received FDA clearance.

NEW YORK – Cue Health said on Monday that it has submitted to the US Food and Drug Administration for full clearance of its molecular test for COVID-19 for at-home and point-of-care use.

The firm said it has made a de novo submission to the agency.

The Cue COVID-19 Test received Emergency Use Authorization from the FDA in March 2021. Full clearance from the agency "would provide the public with a molecular COVID-19 test that has been fully reviewed by the FDA for safety and effectiveness," San Diego-based Cue Health said in a statement. It added that in its prior FDA EUA submission, the test demonstrated 98.9 percent accuracy, while an independent Mayo Clinic study showed it had 97.8 percent overall concordance with central lab-based PCR testing.

More than two years into the COVID-19 pandemic, the FDA has recently encouraged test makers to pursue full clearance and/or approval for their COVID-19 tests. To date, only BioMeriéux subsidiary BioFire Diagnostics has had its COVID-19 tests receive clearance from the FDA. Its FilmArray RP2.1 received de novo clearance in March 2021, and its BioFire COVID-19 Test 2 received 510(k) clearance in November 2021.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.